CIK 0001840229
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- 4 Grant or award Director acquired 1,173 shares (grant or award)
- 4 Grant or award Director acquired 2,494 shares (grant or award)
- 4 Grant or award Director acquired 2,267 shares (grant or award)
- 4 Grant or award Director acquired 1,883 shares (grant or award)
- 4 Grant or award Director acquired 1,953 shares (grant or award)
- 4 Grant or award Director acquired 2,476 shares (grant or award)
- 4 Grant or award Director acquired 1,536 shares (grant or award)
- 4 Grant or award Director acquired 1,849 shares (grant or award)
- 4 Grant or award Director acquired 1,593 shares (grant or award)
- 4 Grant or award Director acquired 2,019 shares (grant or award)
- 4 Grant or award Director acquired 2,033 shares (grant or award)
- 4 Grant or award Director acquired 12,286 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 24,229 shares (grant or award)
- 4 Grant or award Director acquired 24,400 shares (grant or award)
- 4 Grant or award Director acquired 20,987 shares (grant or award)
- 4 Grant or award Director acquired 20,476 shares (grant or award)
- 4 Grant or award Director acquired 21,649 shares (grant or award)
- 4 Grant or award Director acquired 18,753 shares (grant or award)
- 4 Grant or award Director acquired 18,295 shares (grant or award)
Page 3 of 8 · 145 filings